Phio Pharmaceuticals Corp (NASDAQ:PHIO)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - PHIO
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - PHIO
- Market Cap$16.710m
- SymbolNASDAQ:PHIO
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS71880W3034
Company Profile
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Latest PHIO news
Currently there for this company. Visit our news hub for other news .